Pramlintide News

Latest Pramlintide News from Pharmaceutical Industry Today

Drugs > Pramlintide

Amylin Pharma Q1 Loss Widens
26 Apr 15:30 GMT

… :15 AM ET (RTTNews) - Amylin Pharmaceuticals, Inc. (AMLN: News ) said its … ) injection, $23.1 million for SYMLIN (pramlintide acetate) injection and $6.9 … breaking news email alerts for Amylin Pharmaceuticals Inc and others in your …
Amylin's Long-Awaited Therapy For Lipodystrophy Goes to FDA
4 Apr 02:43 GMT

… Amylin Pharmaceuticals Inc.'s metreleptin (recombinant methionyl human leptin) in diabetes … diabetes mellitus, fasting triglycerides over 200 or insulin resistance. With three years treatment … pramlintide …
Is Your Medication Causing Weight Gain?
22 Mar 01:59 GMT

… include SSRI class drugs, such as citalopram … . Diabetes Medications A great way to control diabetes is … These include rosiglitazone, glyburide, insulin, pioglitazone and glipizide. … , exenatide, liraglutide and pramlintide. Talk to your doctor before …
Amylin Pharmaceuticals Announces Pricing of Public Offering of Common Stock
8 Mar 14:13 GMT

… jurisdiction. About Amylin Pharmaceuticals Amylin Pharmaceuticals is a … medicines. Amylin is committed to delivering novel therapies that transform the way diabetes … exenatide) injection, SYMLINÂ® (pramlintide acetate) injection … for BYETTA, SYMLIN or BYDUREON. …
Amylin Pharmaceuticals Announces Public Offering of Common Stock
7 Mar 21:53 GMT

… jurisdiction. About Amylin Pharmaceuticals Amylin Pharmaceuticals is a … medicines. Amylin is committed to delivering novel therapies that transform the way diabetes … exenatide) injection, SYMLINÂ® (pramlintide acetate) injection … for BYETTA, SYMLIN or BYDUREON. …
Weight affected by some medications
26 Feb 21:13 GMT

… added. Common medications and their weight side effects include drugs for: Diabetes: -- … exenatide; Januvia, or sitagliptin; Symlin, or pramlintide; Metformin; and Precose, or acarbose …
Amylin Pharmaceuticals Posts 4Q and Full Year 2011 Financial Results [Professional Services Close - Up]
11 Feb 10:11 GMT

… Close - Up] Amylin Pharmaceuticals, Inc. reported financial … for the treatment of type 2 diabetes. … .3 million for SYMLIN (pramlintide acetate) injection. This … medicines. Amylin is committed to delivering novel therapies that transform the way diabetes …
Amylin reports Q4 sales slump, touts Bydureon potential
7 Feb 21:30 GMT

… week after the FDA approved its weekly diabetes 2 drug, Bydureon (exenatide extended … the year before. Sales for diabetes injection Symlin (Pramlintide) rose 8%, to $28 … 3 trials next year. Former partner Eli Lilly remains part of Amylin …
Amylin Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
6 Feb 21:48 GMT

… .S. Food and Drug Administration (FDA) approval for … for the treatment of type 2 diabetes. BYDUREON … 28.3 million for SYMLIN® (pramlintide acetate) injection. This … with GAAP. About Amylin Pharmaceuticals Amylin Pharmaceuticals is a biopharmaceutical …
Amylin Outlines Corporate Strategy to Maximize Global Value of Diabetes Franchise and Advance Key Pipeline Candidates
17 Jan 22:30 GMT

… Drug Administration (FDA) and has a Prescription Drug … ) injection and SYMLIN® (pramlintide acetate) injection … diabetes using mealtime insulin … Amylin's corporate website, located at www.amylin.com. About Amylin Pharmaceuticals Amylin Pharmaceuticals …
Amylin Outlines Corporate Strategy to Maximize Global Value of Diabetes Franchise and Advance Key Pipeline Candidates
9 Jan 22:39 GMT

… Drug Administration (FDA) and has a Prescription Drug … injection and SYMLIN(Â®) (pramlintide acetate) injection, … 2 diabetes using mealtime insulin … Amylin's corporate website, located at www.amylin.com. About Amylin Pharmaceuticals Amylin Pharmaceuticals …
Amylin Outlines Corporate Strategy to Maximize Global Value of Diabetes Franchise and Advance Key Pi
9 Jan 22:15 GMT

… Drug Administration (FDA) and has a Prescription Drug … injection and SYMLIN((R)) (pramlintide acetate) injection, … 2 diabetes using mealtime insulin … Amylin's corporate website, located at www.amylin.com. About Amylin PharmaceuticalsAmylin Pharmaceuticals …
Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
3 Jan 13:05 GMT

… medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(Â®) (pramlintide … information about Amylin Pharmaceuticals is available at www.amylin.com. SOURCE Amylin Pharmaceuticals, Inc. Copyright …
NovoLog (Type 2 Diabetes) - Analysis and Forecasts to 2020
28 Dec 10:52 GMT

… 39;s pharmaceuticals report, "NovoLog (Type 2 Diabetes) – Analysis … Treatments 18 6 Medications 19 6.1 Insulin 19 6.2 Oral Medications … Other Injectionable Medications 24 6.3.1 Pramlintide 24 6 … Phase III Clinical Trials 13 Table 6: Diabetes, Worldwide, …
Amylin Pharmaceuticals to Present at the 23rd Annual Piper Jaffray Healthcare Conference
23 Nov 21:21 GMT

… medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLINÂ® (pramlintide … information about Amylin Pharmaceuticals is available at www.amylin.com. SOURCE Amylin Pharmaceuticals, Inc. Copyright …
Amylin Pharmaceuticals Announces Date and Time Change to Previously Announced Presentation at the Credit Suisse 2011 Hea
9 Nov 13:57 GMT

… medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLINÂ® (pramlintide … information about Amylin Pharmaceuticals is available at www.amylin.com. SOURCE Amylin Pharmaceuticals, Inc. Copyright …
Amylin Pharmaceuticals Announces Date and Time Change to Previously Announced Presentation at the Credit Suisse 2011 ...
9 Nov 13:25 GMT

… any necessary audio software. About Amylin Pharmaceuticals Amylin Pharmaceuticals is a biopharmaceutical company dedicated … innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide …
Amylin Pharmaceuticals to Present at the Credit Suisse 2011 Healthcare Conference
2 Nov 20:42 GMT

… medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLINÂ® (pramlintide … information about Amylin Pharmaceuticals is available at www.amylin.com. SOURCE Amylin Pharmaceuticals, Inc. Copyright …
Byetta Approved for Use with Insulin Glargine in the U.S.
28 Oct 00:22 GMT

… insulin titration. After 30 weeks of treatment … Medication Guide ( www.Byetta.com/mg ). About Amylin and Lilly Amylin Pharmaceuticals … medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide …
Dapagliflozin: An emerging treatment option for type 2 diabetes mellitus
21 Oct 18:26 GMT

… insulin secretion and/or insufficient action of insulin (insulin … treatment involves diabetes self-management education, medical nutrition therapy, and physical exercise. Diabetes … drugs has yet to be established.1 Pramlintide, an amylin …
Amylin Partners with JDRF to Evaluate Co-Formulation of Symlin with Insulin
10 May 13:55 GMT

Amylin Pharmaceuticals and the Juvenile Diabetes Research Foundation (JDRF) … Amylin’s injectable pramlintide drug Symlin® with insulin for the treatment of type 1 diabetes. Symlin … trials, in order to evaluate whether a fixed ratio of pramlintide and insulin …

1 2 3 4 5 6 7 8 Next

PHARMACEUTICAL INDUSTRY TODAY			BACK TO TOP

Account Info:

My Account
Subscriber Billing Info
Member Center
- Change your billing and/or user information
- Extend your subscription period
- Re-activate an expired account
- Manage your Email Alerts
- Add additional users to your account
- Manage your additional user account(s)
- Retrieve a lost password
- Get an invoice for your subscription
- Cancel your account by sending us an email through the feedback form

Create an Account:

Help & Information Center:

Submit

About

Navigate:

Tools and Formats:

EIN News Home
About EIN News

Founded in 1995, EIN News is an international leader in real-time news tracking and digital information services. Our systems continuously scan the web, indexing news from thousands of worldwide sources. The data is then filtered and organized into news streams. The process is supervised by a team of professional news editors.

We are news professionals and technologists dedicated to producing the fastest and most comprehensive news streams on the planet. We are committed to providing our members with the highest quality software tools and resources available.

EIN News is a division of Internet Product Development Group Inc.
To reach us send an email or call +1 202 657 5158.
EIN Presswire
EIN Marketplace
EIN Events and Conferences
Newsfeed Maker
Inbox Robot
IPD Group
EIN Twitter
EIN Facebook

+ Pharmaceutical Industry Today = Unlimited access to real-time news

Create your EIN News account now.

ALL NEWS PUBLICATIONS

EIN News provides breaking news coverage on the following topics: